Steele Glenn Jr Md Phdinsider trades
In SEC Form 4 filings, Steele Glenn Jr Md Phd is listed as Director of Ptc Therapeutics, Inc. (PTCT). In the last 90 days, Steele Glenn Jr Md Phd sold $781.9K of Ptc Therapeutics, Inc. (PTCT) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PTCTPtc Therapeutics, Inc. | Director | 3 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PTCTPtc Therapeutics, Inc. | Sep 30 | Oct 2 | M | 12,000 | $11.23 | $134,760 | 34,500 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Sep 30 | Oct 2 | S | 12,000 | $65.16 | Sale −$781,920 | 22,500 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Sep 30 | Oct 2 | M · derivative | 12,000 | $11.23 | $134,760 | not reported | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.